4016-2025 - Contract modification
Spain – Pharmaceutical products – Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
OJ S 3/2025 06/01/2025
Contract modification notice
Supplies
1. Buyer
1.1.
Buyer
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Email: contrata@osakidetza.eus
2. Procedure
2.1.
Procedure
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Description: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Procedure identifier: ed851116-4dfb-4841-99c6-381b2c3cff88
Internal identifier: 2020/00887
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
2.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
2.1.4.
General information
Legal basis: 
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0001
Title: 1 - NEVIRAPINA (DOE) comprimido
Description: NEVIRAPINA (DOE) comprimido
Internal identifier: 1 - NEVIRAPINA (DOE) comprimido
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0002
Title: 2 - SOMATOSTATINA (DOE) 0,25 MG vial/ampolla
Description: SOMATOSTATINA (DOE) 0,25 MG vial/ampolla
Internal identifier: 2 - SOMATOSTATINA (DOE) 0,25 MG vial/ampolla
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0003
Title: 3 - SOMATOSTATINA (DOE) 3 MG vial/ampolla
Description: SOMATOSTATINA (DOE) 3 MG vial/ampolla
Internal identifier: 3 - SOMATOSTATINA (DOE) 3 MG vial/ampolla
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0004
Title: 4 - SOMATOSTATINA (DOE) 6 MG vial/ampolla
Description: SOMATOSTATINA (DOE) 6 MG vial/ampolla
Internal identifier: 4 - SOMATOSTATINA (DOE) 6 MG vial/ampolla
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0005
Title: 5 - FIBRINÓGENO HUMANO (DOE) 1 G
Description: FIBRINÓGENO HUMANO (DOE) 1 G
Internal identifier: 5 - FIBRINÓGENO HUMANO (DOE) 1 G
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0006
Title: 6 - DEXMEDETOMIDINA (DOE) 200 MCG Y 1.000 MCG
Description: DEXMEDETOMIDINA (DOE) 200 MCG Y 1.000 MCG
Internal identifier: 6 - DEXMEDETOMIDINA (DOE) 200 MCG Y 1.000 MCG
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0007
Title: 7 - DEXMEDETOMIDINA (DOE) 400 MCG
Description: DEXMEDETOMIDINA (DOE) 400 MCG
Internal identifier: 7 - DEXMEDETOMIDINA (DOE) 400 MCG
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0008
Title: 8 - NITISINONA (DOE) 2 MG, 5 MG Y 10 MG
Description: NITISINONA (DOE) 2 MG, 5 MG Y 10 MG
Internal identifier: 8 - NITISINONA (DOE) 2 MG, 5 MG Y 10 MG
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0009
Title: 9 - NITISINONA (DOE) 20MG Y 4MG/ML
Description: NITISINONA (DOE) 20MG Y 4MG/ML
Internal identifier: 9 - NITISINONA (DOE) 20MG Y 4MG/ML
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract: 
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
6. Results
Value of all contracts awarded in this notice: 1 435 327,40 EUR
6.1.
Result lot identifier: LOT-0003
6.1.2.
Information about winners
Winner: 
Official name: GP - PHARM, S.A.
Tender: 
Tender identifier: 341317
Identifier of lot or group of lots: LOT-0003
Value of the tender: 21 420,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000003
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0004
6.1.2.
Information about winners
Winner: 
Official name: LABORATORIOS NORMON, S.A.
Tender: 
Tender identifier: 341318
Identifier of lot or group of lots: LOT-0004
Value of the tender: 22 770,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000001
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0005
6.1.2.
Information about winners
Winner: 
Official name: CSL BEHRING, S.A.
Tender: 
Tender identifier: 341319
Identifier of lot or group of lots: LOT-0005
Value of the tender: 862 500,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000002
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0006
6.1.2.
Information about winners
Winner: 
Official name: ORION PHARMA, S.L.
Tender: 
Tender identifier: 341320
Identifier of lot or group of lots: LOT-0006
Value of the tender: 83 025,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000004
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0007
6.1.2.
Information about winners
Winner: 
Official name: ORION PHARMA, S.L.
Tender: 
Tender identifier: 341321
Identifier of lot or group of lots: LOT-0007
Value of the tender: 2 050,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000004
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0008
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, S.L.
Tender: 
Tender identifier: 341322
Identifier of lot or group of lots: LOT-0008
Value of the tender: 234 000,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000005
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
6.1.
Result lot identifier: LOT-0009
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, S.L.
Tender: 
Tender identifier: 341323
Identifier of lot or group of lots: LOT-0009
Value of the tender: 209 562,40 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: 2020/00887252_00000000000000000000005
Title: Suministro de Nevirapina (DOE), Somatostatina (DOE), Fibrinógeno humano (DOE), Dexmedetomidina (DOE) y Nitisinona (DOE)
Date of the conclusion of the contract: 23/12/2020
7. Modification
7.1.
Modification
Identifier of the previous contract award notice: 017493-2021
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 23025.6. Incremento del plazo: 12. Fecha Acuerdo: 2021-12-24+01:00. Fecha finalización: 2022-12-23+01:00. Prórroga 2: Importe de la prórroga: 23025.6. Incremento del plazo: 12. Fecha Acuerdo: 2022-12-24+01:00. Fecha finalización: 2023-12-23+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0003
7.1.
Modification
Identifier of the previous contract award notice: 017493-2021
Reason for modification: Need for modifications because of circumstances which a diligent buyer could not predict.
Description: Modificación del objeto 1: Importe de las modificaciones: 12480. Incremento del plazo: 0. Tipo modificación: Modificado. Fecha Acuerdo: 2021-09-28+02:00. Fecha Finalización: 2021-12-23+01:00. Prórroga 1: Importe de la prórroga: 36160.8. Incremento del plazo: 12. Fecha Acuerdo: 2021-12-24+01:00. Fecha finalización: 2022-12-23+01:00. Prórroga 2: Importe de la prórroga: 36160.8. Incremento del plazo: 12. Fecha Acuerdo: 2022-12-24+01:00. Fecha finalización: 2023-12-23+01:00. Prórroga 3: Importe de la prórroga: 36160.8. Incremento del plazo: 12. Fecha Acuerdo: 2023-12-24+01:00. Fecha finalización: 2024-12-23+01:00. Prórroga 4: Importe de la prórroga: 36160.8. Incremento del plazo: 12. Fecha Acuerdo: 2024-12-23+01:00. Fecha finalización: 2025-12-23+01:00.
7.1.1.
Change
Description of modifications: Modificación del objeto
Section identifier: CON-0001
7.1.
Modification
Identifier of the previous contract award notice: 017493-2021
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 944792.16. Incremento del plazo: 12. Fecha Acuerdo: 2021-12-24+01:00. Fecha finalización: 2022-12-23+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0002
7.1.
Modification
Identifier of the previous contract award notice: 017493-2021
Reason for modification: Modifications based on review clauses or options.
Description: Prórroga 1: Importe de la prórroga: 689778.55. Incremento del plazo: 12. Fecha Acuerdo: 2021-12-24+01:00. Fecha finalización: 2022-12-23+01:00. Prórroga 2: Importe de la prórroga: 689778.55. Incremento del plazo: 12. Fecha Acuerdo: 2022-12-24+01:00. Fecha finalización: 2023-12-23+01:00. Prórroga 3: Importe de la prórroga: 689778.55. Incremento del plazo: 12. Fecha Acuerdo: 2023-12-24+01:00. Fecha finalización: 2024-12-23+01:00. Prórroga 4: Importe de la prórroga: 93144.9. Incremento del plazo: 12. Fecha Acuerdo: 2024-11-22+01:00. Fecha finalización: 2025-12-23+01:00.
7.1.1.
Change
Description of modifications: Prórroga
Section identifier: CON-0004
7.1.
Modification
Identifier of the previous contract award notice: 017493-2021
Reason for modification: Need for modifications because of circumstances which a diligent buyer could not predict.
Description: Modificación del objeto 1: Importe de las modificaciones: 72800. Incremento del plazo: 0. Tipo modificación: Modificado. Fecha Acuerdo: 2021-05-28+02:00. Fecha Finalización: 2021-12-23+01:00. Prórroga 1: Importe de la prórroga: 243282. Incremento del plazo: 12. Fecha Acuerdo: 2021-12-24+01:00. Fecha finalización: 2022-12-23+01:00. Prórroga 2: Importe de la prórroga: 243282. Incremento del plazo: 12. Fecha Acuerdo: 2022-12-24+01:00. Fecha finalización: 2023-12-23+01:00. Prórroga 3: Importe de la prórroga: 243282. Incremento del plazo: 12. Fecha Acuerdo: 2023-12-24+01:00. Fecha finalización: 2024-12-23+01:00. Prórroga 4: Importe de la prórroga: 243282. Incremento del plazo: 12. Fecha Acuerdo: 2024-12-23+01:00. Fecha finalización: 2025-12-23+01:00. Incidencias contractuales 1: Fecha resolución: 2024-03-13+01:00. Importe: 0.
7.1.1.
Change
Description of modifications: Modificación del objeto
Section identifier: CON-0005
8. Organisations
8.1.
ORG-0001
Official name: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Registration number: 63493.0
Postal address: C/ Donostia-San Sebastián, 1
Town: Vitoria-Gasteiz
Postcode: 01010
Country: Spain
Email: oarc@euskadi.eus
Telephone: +34 945018000
Internet address: http://www.ejgv.euskadi.eus
Roles of this organisation: 
Review organisation
8.1.
ORG-0003
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Registration number: S5100023J
Postal address: Alava, 45
Town: Vitoria-Gasteiz
Postcode: 01006
Country: Spain
Contact point: Servicio de Farmacia
Email: contrata@osakidetza.eus
Telephone: +34 945006018
Internet address: http://www.osakidetza.euskadi.net
Roles of this organisation: 
Buyer
Organisation providing additional information about the procurement procedure
8.1.
ORG-0005
Official name: GP - PHARM, S.A.
Registration number: A62408786
Postal address: POLº IND.ELS VINYETS/ELS FOGARS SEC
Town: Sant Quintí de Mediona
Postcode: 08777
Country: Spain
Email: gestioncomercial@gp-pharm.com
Telephone: +34 936649018
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0003
8.1.
ORG-0006
Official name: LABORATORIOS NORMON, S.A.
Registration number: A28456820
Postal address: RONDA DE VALDECARRIZO, 6
Town: Tres Cantos
Postcode: 28760
Country: Spain
Email: pedidos@normon.com
Telephone: +34 918065240
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0004
8.1.
ORG-0007
Official name: CSL BEHRING, S.A.
Registration number: A60805785
Postal address: TARRAGONA Nº141-157 ESC.B PLANTA 18
Town: Barcelona
Postcode: 08014
Country: Spain
Email: pedidos.es@cslbehring.com
Telephone: +34 933671872
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0005
8.1.
ORG-0008
Official name: ORION PHARMA, S.L.
Registration number: B85363166
Postal address: AVDA. ALBERTO ALCOCER 46 B, 7º A
Town: Madrid
Postcode: 28016
Country: Spain
Email: pedidos@orionpharma.com
Telephone: +34 915998601
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0006, LOT-0007
8.1.
ORG-0010
Official name: SWEDISH ORPHAN BIOVITRUM, S.L.
Registration number: B84710623
Postal address: RAMIREZ DE ARELLANO 29- 9
Town: Madrid
Postcode: 28043
Country: Spain
Email: sobi@alloga.es
Telephone: +34 925534195
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0008, LOT-0009
Notice information
Notice identifier/version: fcbb403a-d1a0-4c55-9ca7-23458973832a  -  01
Form type: Contract modification
Notice type: Contract modification notice
Notice subtype: 38
Notice dispatch date: 03/01/2025 10:00:04 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially available: Spanish
Notice publication number: 4016-2025
OJ S issue number: 3/2025
Publication date: 06/01/2025